2025 BioSymposium Agenda: Innovations in technologies – Implantables, Neurotech and Diagnostics

Tuesday 25 March 2025 | 8:30 AM - 6:00 PM AEDT

1079766
DD
days
:
HH
hours
:
MM
min
:
SS
sec

Hooray!

08:30 AM
Guest arrival and registration
08:45 AM
Welcome and opening remarks
09:00 AM
Session one - Implantables and Bioelectronics: Revolutionising Patient Care

Explore innovations in implantable devices, including neurostimulation, bioelectronic medicine, including advances in neural prosthetics, brain-machine interfaces, and spinal cord stimulators.

Professor David Grayden, The Clifford Chair in Neural Engineering, The University of Melbourne

A/Professor Rachael Richardson, Head of Optogenetics Research Program, Bionics Institute

Dr Karolina Petkovic, Team Leader | Biomedical Sensing, CSIRO

10:35 AM
Morning break, networking
11:15 AM
12:30 PM
Lunch break, networking
1:30 PM
Session three - Bridging the Gap: Translating Innovation to Impact

Short presentations on navigating the pathways from research to market, addressing regulatory, funding, and commercialisation challenges. Questions raised for audience consideration. Collaborative discussions and audience engagement interactive polls and Q&A on fostering a strong ecosystem through partnerships between academia, industry, and government.

Chair: Professor Marcus Watson, Enterprise Senior Fellow, Graeme Clark Institute for Biomedical Engineering

Helen Poliviou, Founder/Managing Director, PureCDM

Marc Degli, Co-founder, Blackhawk Alert

Beata Khaidurova, Partner, FB Rice

Dr Pip Karoly, Neuroengineering Scientist & Innovator | NHMRC Emerging Leadership Fellow, The University of Melbourne

Professor David Grayden, The Clifford Chair in Neural Engineering, The University of Melbourne

3:00 PM
Afternoon break, networking
3:30 PM
Session four - Vision for the Future: Implantables, Devices and Diagnostics

Highlighting the future of medtech and its impact on global competitiveness and patient outcomes.

Dr Mary-Beth Brinson, Chief Executive Officer, Cyban Pty Ltd

Dr Ludovic Labat, Chief Executive Officer, Neo-Bionica

Professor Nicholas Opie, Head of Vascular Bionics Laboratory, The University of Melbourne

Jacqui Savage, Founder, MedCorp Technologies

4:55 PM
Closing remarks
5:00 PM
Networking continued
6:00 PM
Close

Home

News & opinion

Member Directory

Events